0EL9 Stock Overview
Operates as a medical technology company in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Geratherm Medical AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.98 |
| 52 Week High | €5.30 |
| 52 Week Low | €2.98 |
| Beta | 0.11 |
| 11 Month Change | -12.35% |
| 3 Month Change | -33.78% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -59.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| 0EL9 | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -16.8% | 5.6% | -0.3% |
| 1Y | n/a | -1.6% | 6.1% |
Return vs Industry: Insufficient data to determine how 0EL9 performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0EL9 performed against the UK Market.
Price Volatility
| 0EL9 volatility | |
|---|---|
| 0EL9 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0EL9's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0EL9's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 179 | Christian Frick | www.geratherm.com |
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors.
Geratherm Medical AG Fundamentals Summary
| 0EL9 fundamental statistics | |
|---|---|
| Market cap | €14.85m |
| Earnings (TTM) | -€830.50k |
| Revenue (TTM) | €18.31m |
0.8x
P/S Ratio-17.9x
P/E RatioIs 0EL9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0EL9 income statement (TTM) | |
|---|---|
| Revenue | €18.31m |
| Cost of Revenue | €4.91m |
| Gross Profit | €13.39m |
| Other Expenses | €14.22m |
| Earnings | -€830.50k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 73.16% |
| Net Profit Margin | -4.54% |
| Debt/Equity Ratio | 30.8% |
How did 0EL9 perform over the long term?
See historical performance and comparison